Cargando…

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells

Epstein–Barr virus (EBV) is implicated as an aetiological factor in B lymphomas and nasopharyngeal carcinoma. The mechanisms of cell-free EBV infection of nasopharyngeal epithelial cells remain elusive. EBV glycoprotein B (gB) is the critical fusion protein for infection of both B and epithelial cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hong-Bo, Zhang, Hua, Zhang, Jing-Ping, Li, Yan, Zhao, Bo, Feng, Guo-Kai, Du, Yong, Xiong, Dan, Zhong, Qian, Liu, Wan-Li, Du, Huamao, Li, Man-Zhi, Huang, Wen-Lin, Tsao, Sai Wah, Hutt-Fletcher, Lindsey, Zeng, Yi-Xin, Kieff, Elliott, Zeng, Mu-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339892/ https://www.ncbi.nlm.nih.gov/pubmed/25670642 http://dx.doi.org/10.1038/ncomms7240

Ejemplares similares

Efficient Immortalization of Primary Nasopharyngeal Epithelial Cells for EBV Infection Study
por: Yip, Yim Ling, et al.
Publicado: (2013)

Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma
por: Lee, Hui Min, et al.
Publicado: (2020)

Enhanced IL-6/IL-6R Signaling Promotes Growth and Malignant Properties in EBV-Infected Premalignant and Cancerous Nasopharyngeal Epithelial Cells
por: Zhang, Guitao, et al.
Publicado: (2013)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
por: Li, Jiang, et al.
Publicado: (2007)

Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis
por: Lu, Zheng-Zhou, et al.
Publicado: (2023)

Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma
por: Xu, Yu, et al.
Publicado: (2013)

CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma
por: Lun, Samantha Wei-Man, et al.
Publicado: (2012)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis
por: Cheung, Chartia Ching-Mei, et al.
Publicado: (2014)

EBV‐encoded miRNAs target ATM‐mediated response in nasopharyngeal carcinoma
por: Lung, Raymond W‐M, et al.
Publicado: (2018)

mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation
por: Chan, King Chi, et al.
Publicado: (2013)

EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC
por: Yan, Qijia, et al.
Publicado: (2015)

EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity
por: Zhu, Nannan, et al.
Publicado: (2021)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma
por: Lin, Weitao, et al.
Publicado: (2018)

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection
por: Guo, Can, et al.
Publicado: (2006)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma
por: Huang, Shaina Chor Mei, et al.
Publicado: (2018)

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
por: Yuan, Li, et al.
Publicado: (2022)

Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma
por: Xie, Jiajun, et al.
Publicado: (2021)

Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
por: Hau, Pok Man, et al.
Publicado: (2011)

N(6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
por: Xia, Tian‐Liang, et al.
Publicado: (2021)

Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
por: Yu, Justin, et al.
Publicado: (2021)

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
por: Cantuti-Castelvetri, Ludovico, et al.
Publicado: (2020)

Long‐term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma
por: Li, Wanxia, et al.
Publicado: (2020)

Identification of a recurrent transforming UBR5–ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma
por: Chung, Grace TY, et al.
Publicado: (2013)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
por: Liu, Weixing, et al.
Publicado: (2021)

EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
por: Lyu, Xiaoming, et al.
Publicado: (2018)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
por: Yang, Tingting, et al.
Publicado: (2022)

Correction: EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
por: Lyu, Xiaoming, et al.
Publicado: (2020)

EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
por: Li, Zhi, et al.
Publicado: (2015)

EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma
por: Ding, Tengteng, et al.
Publicado: (2023)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
por: Cao, Ya
Publicado: (2017)

A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China
por: Xue, Wen-Qiong, et al.
Publicado: (2021)

A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China
por: He, Qiao, et al.
Publicado: (2023)

Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin
por: Chan, King Chi, et al.
Publicado: (2015)

Neuropilin 1 modulates TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer
por: Ding, Zongli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e0knives6grp8khjsbf1jh1vf3